Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2013-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jaci.2013.05.036PMID 23890755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational Studies

  2013cited by this paper
• FcγRIII (CD16) equips immature 6-sulfo LacNAc-expressing dendritic cells (slanDCs) with a unique capacity to handle IgG-complexed antigens.

  2013cited by this paper
• TRAIL+ Human Plasmacytoid Dendritic Cells Kill Tumor Cells In Vitro: Mechanisms of Imiquimod- and IFN-α–Mediated Antitumor Reactivity

  2012cited by this paper
• Faculty Opinions recommendation of Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.

  2012cited by this paper
• Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β

  2012cited by this paper
• The three human monocyte subsets: implications for health and disease

  2012cited by this paper
• Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta‐analysis of randomized controlled trials

  2012cited by this paper
• The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population.

  2012cited by this paper
• Human 6‐sulfo LacNAc (slan) dendritic cells are a major population of dermal dendritic cells in steady state and inflammation

  2012cited by this paper
• The concept of psoriasis as a systemic inflammation: implications for disease management

  2012cited by this paper
• Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets.

  2011cited by this paper
• SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset.

  2011cited by this paper
• Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses.

  2011cited by this paper
• Nomenclature of monocytes and dendritic cells in blood.

  2010cited by this paper
• Host defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-/IL-17-producing CD8+ T cells?

  2010cited by this paper
• Host Defense Mechanisms in Secondary Syphilitic

  2010cited by this paper
• A subpopulation of CD163-positive macrophages is classically activated in psoriasis.

  2010cited by this paper
• Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling

  2010cited by this paper
• Transmembrane TNF-α: structure, function and interaction with anti-TNF agents

  2010cited by this paper
• Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis.

  2010cited by this paper
• Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors

  2010cited by this paper
• Clinical and Cytological Effects of Pimecrolimus Cream 1% after Resolution of Active Atopic Dermatitis Lesions by Topical Corticosteroids: A Randomized Controlled Trial

  2010cited by this paper
• Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.

  2010cited by this paper
• Mechanisms of Disease: Psoriasis.

  2009cited by this paper
• Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor.

  2009cited by this paper
• Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.

  2009cited by this paper
• Differences in binding and effector functions between classes of TNF antagonists.

  2009cited by this paper
• Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells.

  2009cited by this paper
• Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab.

  2008cited by this paper
• Tumor necrosis factor antagonist mechanisms of action: a comprehensive review.

  2008cited by this paper
• Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.

  2007cited by this paper
• Pathogenesis and clinical features of psoriasis.

  2007cited by this paper
• Literature Watch

  2007cited by this paper
• Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages.

  2007cited by this paper
• Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells

  2007cited by this paper
• Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes.

  2006cited by this paper
• Protein Expression of TNF-α in Psoriatic Skin Is Regulated at a Posttranscriptional Level by MAPK-Activated Protein Kinase 21

  2006cited by this paper
• Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a).

  2005cited by this paper
• Psoriasis assessment tools in clinical trials

  2005cited by this paper
• Characterization of human blood dendritic cell subsets.

  2002cited by this paper
• 6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells.

  2002cited by this paper
• Psoriasis − epidemiology and clinical spectrum

  2001cited by this paper
• Tumor necrosis factor alpha (TNFα) in human skin: a comparison of different antibodies for immunohistochemistry

  2001cited by this paper
• Detection of membrane‐bound tumor necrosis factor (TNF): An analysis of TNF‐specific reagents

  2000cited by this paper
• An important role of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasis.

  1998cited by this paper
• A novel dendritic cell population in human blood: one‐step immunomagnetic isolation by a specific mAb (M‐DC8) and in vitro priming of cytotoxic T lymphocytes

  1998cited by this paper
• An important role of tumor necrosis factor-α in the induction of adhesion molecules in psoriasis

  1998cited by this paper
• Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-α and their degranulation is associated with expression of ICAM-1 in the epidermis

  1998cited by this paper
• Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining.

  1996cited by this paper
• Localization of tumour necrosis factor‐alpha (TNF‐α) and its receptors in normal and psoriatic skin: epidermal cells express the 55‐kD but not the 75‐kD TNF receptor

  1993cited by this paper
• Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.

  1991cited by this paper
• A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF.

  1988cited by this paper

• Systemic CSF1R Targeting Depletes Pathogenic MPS Bubs and Ameliorates Psoriasis via PPARα-mediated Resolution

  2026cites this paper
• Euphorbia humifusa Willd. extract alleviates imiquimod-induced psoriasis-like skin lesions in mice by modulating the IL-17 signaling pathway.

  2025cites this paper
• Extracorporeal shockwave therapy ameliorates skin inflammation of imiquimod-induced psoriasis in mice.

  2025cites this paper
• Targeting Inflammatory Cytokines in Autoimmune Diseases: Mechanisms and Therapeutic Advances with Antibody-Based Therapies

  2025cites this paper
• Targeting KAT8 alleviates self-RNA-driven skin inflammation by modulating histone H4 lysine 16 acetylation in psoriasis

  2025cites this paper
• Apigenin suppresses keratinocyte hyperproliferation and inflammation in psoriasis by inhibiting CDK2/E2F2 pathway.

  2025cites this paper
• Biochanin A Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Modulating the NF-κB and MAPK Signaling Pathways

  2024cites this paper
• Pyoderma gangrenosum during infliximab in severe hidradenitis suppurativa: A paradoxical event

  2024cites this paper
• Circulating Monocytes are Predictive and Responsive in Moderate-to-Severe Plaque Psoriasis Subjects Treated with Apremilast.

  2024cites this paper
• Macrophages mediate psoriasis via Mincle-dependent mechanism in mice

  2023cites this paper
• Effect of DMARDs on the immunogenicity of vaccines

  2023cites this paper
• Efficacy of guselkumab compared with adalimumab for psoriasis: a meta-analysis of randomized controlled studies

  2022cites this paper
• T he role of cells of the innate immune system in psoriasis

  2022cites this paper
• Role of innate immune system cells in psoriasis

  2022cites this paper
• Differential Effects of Anti-TNFα and Anti-α4β7 Drugs on Circulating Dendritic Cells Migratory Capacity in Inflammatory Bowel Disease

  2022cites this paper
• Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis

  2022cites this paper
• Role of chemokine systems in cancer and inflammatory diseases

  2022cites this paper
• CCR6-CCL20 axis as a therapeutic target for autoimmune diseases.

  2021cites this paper
• Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis

  2021influential citation
• The therapeutic effects of Bombyx mori sericin on rat skin psoriasis through modulated epidermal immunity and attenuated cell proliferation

  2021cites this paper
• Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade

  2021cites this paper
• IL23 Promotes Antimicrobial Pathways in Human Macrophages, Which Are Reduced With the IBD-Protective IL23R R381Q Variant

  2020cites this paper
• The CCL20 and CCR6 axis in psoriasis

  2020cites this paper
• Inhibition of SHP2 ameliorates psoriasis by decreasing TLR7 endosome localization

  2020cites this paper
• Human innate immune cell crosstalk induces melanoma cell senescence

  2020cites this paper
• Inflammation in Hypertension.

  2020cites this paper
• The contribution of IL-17 to the development of autoimmunity in psoriasis

  2019cites this paper
• Psoriasis and the TNF/IL23/IL17 axis.

  2019cites this paper
• Anti-TNF- αtreatment-related pathways and biomarkers revealed by transcriptome analysis in Chinese psoriasis patients

  2019cites this paper
• Cyto/chemokine profile of in vitro scratched keratinocyte model: Implications of significant upregulation of CCL20, CXCL8 and IL36G in Koebner phenomenon.

  2019cites this paper
• Current Concepts on 6-sulfo LacNAc Expressing Monocytes (slanMo)

  2019influential citation
• Dendritic cells: The driver of psoriasis

  2019cites this paper
• Tildrakizumab for the treatment of psoriasis.

  2018cites this paper
• Human Langerhans Cells with Pro-inflammatory Features Relocate within Psoriasis Lesions

  2018cites this paper
• Primary and secondary immunodeficiencies of the IL-12/IFN-γ axis

  2018cites this paper
• Analysis of anti‐tumour necrosis factor‐induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics

  2018cites this paper
• Granulocyte and monocyte adsorption apheresis for palmoplantar pustulosis with extra‐palmoplantar lesions and pustulotic arthro‐osteitis

  2018cites this paper
• Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT3, interleukin 6 and hydrogen peroxide

  2018cites this paper
• Dynamic Changes in Resident and Infiltrating Epidermal Dendritic Cells in Active and Resolved Psoriasis.

  2017influential citation
• Efficacy and safety of guselkumab, an anti‐interleukin‐23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double‐blind, placebo‐ and active comparator–controlled VOYA

  2017cites this paper
• Immunological Changes in Blood of Newborns Exposed to Anti-TNF-α during Pregnancy

  2017cites this paper
• Drug‐induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum

  2017cites this paper
• An in vitro investigation of the marked impact of dendritic cell interactions with bone grafts.

  2017cites this paper
• Abnormalities in the Adhesion and Aggregation Profiles of Circulating Monocytes in Psoriasis

  2016cites this paper
• Current knowledge on psoriasis and autoimmune diseases

  2016cites this paper
• The single‐chain anti‐TNF‐α antibody DLX105 induces clinical and biomarker responses upon local administration in patients with chronic plaque‐type psoriasis

  2016cites this paper
• Recent advances in understanding psoriasis

  2016cites this paper
• Antigen- bzw. Allergenpräsentation

  2016influential citation
• Reducing Peripheral Inflammation with Infliximab Reduces Neuroinflammation and Improves Cognition in Rats with Hepatic Encephalopathy

  2016cites this paper
• Resident T cells in human skin : functional heterogeneity and clinical implications

  2016cites this paper
• Human mononuclear phagocyte system reunited.

  2015cites this paper
• CCL7 contributes to the TNF‐alpha‐dependent inflammation of lesional psoriatic skin

  2015cites this paper
• Differential accumulation and function of proinflammatory 6‐sulfo LacNAc dendritic cells in lymph node and colon of Crohn's versus ulcerative colitis patients

  2015cites this paper
• Chronic Psoriatic Skin Inflammation Leads to Increased Monocyte Adhesion and Aggregation

  2015cites this paper
• Aggregation to Increased Monocyte Adhesion and Chronic Psoriatic Skin Inflammation Leads

  2015cites this paper
• Adalimumab in the treatment of moderate‐to‐severe chronic plaque psoriasis in patients switching from other biologics

  2015cites this paper
• [Seafood allergy in cooks: a case series and review of the literature].

  2014cites this paper
• γδ T Cells Are Required for Pulmonary IL-17A Expression after Ozone Exposure in Mice: Role of TNFα

  2014cites this paper
• Die Bedeutung von humanen 6‐sulfo LacNAc dendritischen Zellen (slanDCs) bei Autoimmunität und Tumorerkrankungen

  2014cites this paper
• Specific roles for dendritic cell subsets during initiation and progression of psoriasis

  2014cites this paper
• The pathophysiological role of dendritic cell subsets in psoriasis

  2014cites this paper
• The role of human 6‐sulfo LacNAc dendritic cells (slanDCs) in autoimmunity and tumor diseases

  2014cites this paper
• [What's new in dermatological research?].

  2013cites this paper
• Quoi de neuf en recherche dermatologique

  2013cites this paper
• Recent advances in understanding psoriasis

  year unknowncites this paper